The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2

The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2

The search for effective methods to detect patients who excrete a viable virus is one of the urgent tasks of modern biomedicine. In the present study, we examined the diagnostic value of two antigen tests, BIOCREDIT COVID-19 Ag (RapiGEN Inc., Anyang, Korea) and SGTI-flex COVID-19 Ag (Sugentech Inc.,...

Full description

Bibliographic Details
Main Authors: Elena V. Shidlovskaya, Nadezhda A. Kuznetsova, Elizaveta V. Divisenko, Maria A. Nikiforova, Andrei E. Siniavin, Daria A. Ogarkova, Aleksandr V. Shagaev, Maria A. Semashko, Artem P. Tkachuk, Olga A. Burgasova, Vladimir A. Gushchin
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
viable virus
rapid antigen tests
Online Access:https://www.mdpi.com/1999-4915/13/10/2012

Internet

https://www.mdpi.com/1999-4915/13/10/2012

Similar Items